{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:00:04Z","timestamp":1775322004786,"version":"3.50.1"},"reference-count":31,"publisher":"Japan Atherosclerosis Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb"],"published-print":{"date-parts":[[1996]]},"DOI":"10.5551\/jat1994.3.95","type":"journal-article","created":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T23:04:58Z","timestamp":1395356698000},"page":"95-104","source":"Crossref","is-referenced-by-count":13,"title":["A Coronary Primary Intervention Study of Japanese Men : Study Design, Implementation and Baseline Data"],"prefix":"10.5551","volume":"3","author":[{"family":"The Kyushu Lipid Intervention Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"(1) The Pooling Project Research Group : Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to major coronary events : final report of the Pooling Project. J Chronic Dis, 31 : 201-306, 1978","DOI":"10.1016\/0021-9681(78)90073-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"(2) Pocock SJ, Shaper AG, and Phillips AN : Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischemic heart disease. BMJ, 298 : 998-1002, 1989","DOI":"10.1136\/bmj.298.6679.998"},{"key":"3","doi-asserted-by":"crossref","unstructured":"(3) Rosengren A, Welin L, Tsipogianni A, and Wilhelmsen L : Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men : A general population study. BMJ, 299 : 1127-1131, 1989","DOI":"10.1136\/bmj.299.6708.1127"},{"key":"4","doi-asserted-by":"crossref","unstructured":"(4) Stamler J, Wentworth D, and Neaton JD for the MRFIT Research Group : Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous or graded ? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA, 256 : 2823-2828, 1986","DOI":"10.1001\/jama.1986.03380200061022"},{"key":"5","doi-asserted-by":"crossref","unstructured":"(5) Committee of Principal Investigators : A co-operative trial in the primary prevention of ischemic heart disease using clofibrate. Br Heart J, 40 : 1069-1118, 1978","DOI":"10.1136\/hrt.40.10.1069"},{"key":"6","doi-asserted-by":"crossref","unstructured":"(6) Committee of Principal Investigators : W.H.O. co-operative trial on primary prevention of ischemic heart disease using clofibrate to lower serum cholesterol : Mortality follow-up. Lancet, ii : 379-385, 1980","DOI":"10.1016\/S0140-6736(80)90438-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"(7) Lipid Research Clinics Program : The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA, 251 : 351-364, 1984","DOI":"10.1001\/jama.1984.03340270029025"},{"key":"8","doi-asserted-by":"crossref","unstructured":"(8) Lipid Research Clinics Program : The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA, 251 : 365-374, 1984","DOI":"10.1001\/jama.1984.03340270043026"},{"key":"9","doi-asserted-by":"crossref","unstructured":"(9) Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, Maenpaa H, Malkonen M, Manttari M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjoblom T, and Nikkila EA : Helsinki Heart Study : Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med, 317 : 1237-1245, 1987","DOI":"10.1056\/NEJM198711123172001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"(10) Szatrowski TP, Peterson AV Jr, Shimizu Y, Prentice RL, Mason MW, Fukunaga Y, and Kato H : Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohort. J Chronic Dis, 37 : 569-584, 1984","DOI":"10.1016\/0021-9681(84)90007-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"(11) Tsujita Y and Watanabe Y : Pravastatin sodium : A novel cholesterol-lowering agent that inhibits HMG-CoA reductase. Cardiovasc Drug Rev, 7 : 110-126, 1989","DOI":"10.1111\/j.1527-3466.1989.tb00520.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"(12) Saito Y, Goto Y, Nakaya N, Hata Y, Homma Y, Naito C, Hayashi H, Ito H, Yamamoto M, Takeuchi I, Mori K, Hara T, Yoshida S, Shirai K, Sasaki N, Shinomiya M, Murano S, Morisaki N, Nishiide T, Kanzaki T, Watanabe N, and Ishikawa T : Dose-dependent hypolipidemic effect of an inhibitor of HMG-CoA reductase, pravastatin (CS-514), in hypercholesterolemic subjects : A double blind test. Atherosclerosis, 72 : 205-211, 1988","DOI":"10.1016\/0021-9150(88)90082-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"(13) Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH, and Packard CJ for the West of Scotland Coronary Prevention Study Group : Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med, 333 : 1301-1312, 1995","DOI":"10.1056\/NEJM199511163332001"},{"key":"14","doi-asserted-by":"crossref","unstructured":"(14) Consensus Conference : J Jpn Atheroscler Soc, 15 : 1109-1148, 1987","DOI":"10.1042\/bst0151109"},{"key":"15","doi-asserted-by":"crossref","unstructured":"(15) Halperin M, Rogot E, Gurian J, and Ederer F : Sample size for medical trials with special reference to long-term therapy. J Chronic Dis, 21 : 12-24, 1968","DOI":"10.1016\/0021-9681(68)90082-9"},{"key":"16","unstructured":"(16) Ministry of Health and Welfare, Japan : Vital statistics, 1985. Health and Welfare Statistics Association, Tokyo, 1987"},{"key":"17","doi-asserted-by":"crossref","unstructured":"(17) Ueshima H, Tatara K, and Asakura S : Declining mortality from ischemic heart disease and changes in coronary risk factors in Japan, 1956-1980. Am J Epidemiol, 125 : 62-72, 1987","DOI":"10.1093\/oxfordjournals.aje.a114512"},{"key":"18","unstructured":"(18) Uemura K and Pisa Z : Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q, 41 : 155-178, 1988"},{"key":"19","unstructured":"(19) Ministry of Health and Welfare, Japan : National statistics on patients (Kanja-chousa), 1987. Health and Welfare Statistics Association, Tokyo, 1989"},{"key":"20","doi-asserted-by":"crossref","unstructured":"(20) Shimamoto T, Komachi Y, Inada H, Doi M, Iso H, Sato S, Kitamura A, lida M, Konishi M, Nakanishi N, Terao A, Naito Y, and Kojima S : Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation, 79 : 503-515, 1989","DOI":"10.1161\/01.CIR.79.3.503"},{"key":"21","unstructured":"(21) Nakamura Y : Serum total cholesterol and HDL-cholesterol levels in a community population of Kasuya County in connection with age, obesity and blood pressure. Jpn J Public Health, 33 : 73-80, 1986 (in Japanese)"},{"key":"22","unstructured":"(22) Geller NL and Pocock SJ : The consultant's forum. Interim analyses in randomized clinical trials : Ramifications and guidelines for practitioners. Biometrics, 43 : 213-223, 1987"},{"key":"23","doi-asserted-by":"crossref","unstructured":"(23) Muldoon MF, Manuck SB, and Matthews KA : Lowering cholesterol concentrations and mortality : A quantitative review of primary prevention trials. BMJ, 301 : 309-314, 1990","DOI":"10.1136\/bmj.301.6747.309"},{"key":"24","doi-asserted-by":"crossref","unstructured":"(24) Ravnskov U : Cholesterol lowering trials in coronary heart disease : Frequency of citation and outcome. BMJ, 305 : 15-19, 1992","DOI":"10.1136\/bmj.305.6844.15"},{"key":"25","doi-asserted-by":"crossref","unstructured":"(25) Smith GD, Song F, and Sheldon T : Cholesterol lowering and mortality : The importance of considering initial level of risk. BMJ, 306 : 1367-1373, 1993","DOI":"10.1136\/bmj.306.6889.1367"},{"key":"26","doi-asserted-by":"crossref","unstructured":"(26) Law MR, Wald NJ, and Thompson SG : By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease. BMJ, 308 : 367-372, 1994","DOI":"10.1136\/bmj.308.6925.367"},{"key":"27","doi-asserted-by":"crossref","unstructured":"(27) Law MR, Thompson SG, and Wald NJ : Assessing possible hazards of reducing serum cholesterol. BMJ, 308 : 373-379, 1994","DOI":"10.1136\/bmj.308.6925.373"},{"key":"28","doi-asserted-by":"crossref","unstructured":"(28) Scandinavian Simvastatin Survival Study Group : Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease : the Scandinavian Simvastatin Survival Study (4S). Lancet, 344 : 1383-1389, 1994","DOI":"10.1016\/S0140-6736(94)90566-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"(29) Engelberg H : Low serum cholesterol and suicide. Lancet, 339 : 727-729, 1992","DOI":"10.1016\/0140-6736(92)90609-7"},{"key":"30","doi-asserted-by":"crossref","unstructured":"(30) Salter M : Low serum cholesterol and suicide. Lancet, 339 : 1169, 1992","DOI":"10.1016\/0140-6736(92)90768-X"},{"key":"31","doi-asserted-by":"crossref","unstructured":"(31) Steegmans PHA, Fekkes D, Hoes AW, Bak AAA, van der Does E, and Grobbee DE : Low serum cholesterol concentration and serotonin metabolism in men. BMJ, 312 : 221, 1996","DOI":"10.1136\/bmj.312.7025.221"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat1994\/3\/2\/3_2_95\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T19:05:25Z","timestamp":1565291125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat1994\/3\/2\/3_2_95\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996]]}},"URL":"https:\/\/doi.org\/10.5551\/jat1994.3.95","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996]]}}}